Riassunto: GENESIS Pharma espande ad alcuni paesi scandinavi la collaborazione commerciale strategica con Alnylam Pharmaceuticals in materia di terapie RNAi

Key Takeaway: GENESIS Pharma has expanded its strategic commercial collaboration with Alnylam Pharmaceuticals to include certain Scandinavian countries. This partnership focuses on RNAi therapies, enhancing the reach and availability of these treatments in the region. The collaboration aims to leverage both companies' strengths in the biopharmaceutical sector.